- Previous close
12.08 - Open
13.10 - Bid 12.83 x 40000
- Ask 12.85 x 40000
- Day's range
12.85 - 13.14 - 52-week range
10.24 - 15.03 - Volume
157,892 - Avg. Volume
765,467 - Market cap (intra-day)
44.443B - Beta (5Y monthly) 0.09
- PE ratio (TTM)
22.98 - EPS (TTM)
0.56 - Earnings date 23 Oct 2024
- Forward dividend & yield 0.51 (3.92%)
- Ex-dividend date 5 Aug 2024
- 1y target est
13.97
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands. The company also offers home fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfecting sprays wipes, laundry sanitisers, and others; sprays, baits, and plug-ins for pest control; stain removals; and fabric washing under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands. In addition, it provides nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.
www.reckitt.com40,000
Full-time employees
31 December
Fiscal year ends
Consumer Defensive
Sector
Household & Personal Products
Industry
Recent news: RBGLY
View more
Related videos: RBGLY
Performance overview: RBGLY
Trailing total returns as of 04/11/2024, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: RBGLY
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: RBGLY
View moreValuation measures
Market cap
44.45B
Enterprise value
54.65B
Trailing P/E
22.91
Forward P/E
15.04
PEG ratio (5-yr expected)
1.15
Price/sales (ttm)
2.47
Price/book (mrq)
4.25
Enterprise value/revenue
2.96
Enterprise value/EBITDA
13.74
Financial highlights
Profitability and income statement
Profit margin
10.78%
Return on assets (ttm)
7.51%
Return on equity (ttm)
17.91%
Revenue (ttm)
14.33B
Net income avi to common (ttm)
1.54B
Diluted EPS (ttm)
0.56
Balance sheet and cash flow
Total cash (mrq)
986M
Total debt/equity (mrq)
112.52%
Levered free cash flow (ttm)
2.17B